Group One Trading’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Group One Trading's DYN Position: Q3 2026 in Review
Group One Trading increased its Dyne Therapeutics (DYN) stake by 357% in Q3 2026, buying an estimated $30.6K and bringing the position to 1,704 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5661.
Group One Trading first reported a position in DYN in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.05M in Q4 2023. 270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Group One Trading held 1,704 shares of Dyne Therapeutics worth $27.5K as of Q3 2026.
- Group One Trading bought 1,331 Dyne Therapeutics shares in Q3 2026, an estimated $30.6K.
- Dyne Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5661 holding.
- Group One Trading first reported a position in Dyne Therapeutics in Q3 2023 and has held it in 12 quarters since.
- Group One Trading's Dyne Therapeutics position peaked at $1.05M in Q4 2023.
- 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.